Valentina Cannone, MD PhD

Senior Scientific Advisor

Prof. Cannone is Associate Professor of Internal Medicine at the University of Parma, Parma, Italy and Research Collaborator at the Cardiorenal Research Laboratory at Mayo Clinic, Rochester, MN, USA  

Prof. Cannone’s translational research studies have been focused on genetics and cardiometabolic properties of natriuretic peptides. More specifically, Prof. Cannone has analyzed the clinical phenotype and risk associated with genetic variants of natriuretic peptides. In the animal model of hypertension and metabolic syndrome, Prof. Cannone has also investigated the cardiovascular and metabolic actions of MANP, which is a novel ANP-like peptide designed at Mayo Clinic. Importantly, funded by the American Heart Association and Mayo Clinic Department of Cardiovascular Medicine, Prof. Cannone has also served as the Principal Investigator in a clinical study focused on evaluating the acute cardiometabolic action of MANP in subjects with hypertension and metabolic syndrome.

Prof. Cannone has been the recipient of awards from the Heart Failure Society of America and the Italian Society of Arterial Hypertension.

Prof. Cannone’s long-term goal is the development of a natriuretic peptide-based therapy for cardiometabolic disease.